Hi Richard. I always appreciate your comments. I would suggest that you reconsider your disagreement with point 1 (the European Commission's position on the matter). A compliance strategy based on such a position is sure to lead to compliance problems.
Remember that the EU MDR plainly states that instructions for use may be provided to the user in non-paper format (e.g. electronic), but only under the conditions set out in Regulation (EU) No 207/2012. Remember also that Regulation 207/2012 identifies two categories of devices: 1) Those encompassed within Article 3; and 2) those not encompassed within Article 3. Then that Regulation goes on to specify the conditions to be met whenever IFU are provided electronically. Those conditions are generally broken down into two routes: a) provision of eIFU instead of paper (only the Article 3 devices are eligible for this route); and b) provision of eIFU in addition to paper (any device is eligible for that route). Because of these parameters, the Commission would surely not agree that "…nowhere in 207/2012 or 2017/745 does it say eIFUs can apply to all medical devices…". Indeed, EU MDR Annex I 23.1(h) plainly states just that.
For example, during correspondence with the Commission, I asked, "...REGULATION (EU) No 207/2012 preface item (9), and Article 1 (second paragraph), and Article 9, specify requirements to be met when medical device instructions for use are provided in electronic form in addition to paper form. Do these Article 1 (second paragraph) and Article 9 requirements apply to all medical devices, or instead only to the particular devices listed in Article 3?..."
The Directorate General for Health and Food Safety's reply: "...COMMISSION REGULATION (EU) No 207/2012 applies to all medical devices which have instructions for use provided electronically, regardless of whether they also provide paper format or if they benefit from...the use of electronic instead of paper format..." [emphasis added]
The EU MDR can certainly be difficult to understand at times. Nonetheless, given the significant impact of our footprints on the businesses and communities we affect, it is crucial that we achieve accurate understanding. Misinterpretations can do severe damage, and even put lives at risk.
------------------------------
Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
Principal Consultant
Ridgway, CO
United States
© Copyright 2021 by ComplianceAcuity, Inc. All rights reserved.
------------------------------
Original Message:
Sent: 01-Jun-2021 03:58
From: Richard Vincins
Subject: eIFU for Breast Implants in EU
Hi Kevin,
I would have to politely disagree with your point 1. No where in 207/2012 or 2017/745 does it say eIFUs can apply to all medical devices. I can agree Article 1 of 207/2012 could be inferred broadly to any medical device. However, there can be and is still broad interpretations based on the convoluted wording in the regulations. My issue with eIFU use is: continue to have long "conversations" with auditors about this because there is such variation of interpretation when a minor nonconformity is being issued. In fact, even last week working with a client where their Authorised Representative (AR) refused their Technical Documentation because they only had an eIFU for their implant and the AR stated that was not possible. I just take a strong point on this because I continually see pages and pages of IFUs of Class I, IIa, IIb products of 10 languages which are well established, well known, and the users of these device never, ever look at the IFUs - ends up with all the other waste. And a strong point because I recognise this waste of paper, continued destruction of our rain forests, and we should be preventing use, not just saying oh these can be recycled. My stance is the EU Commission needs to stop being bureaucratic and as they state their intent about supporting the planet should take a proactive approach to write clear regulations allowing a risk-based approach of eIFUs of all medical devices to reduce, recycle, and remove paper generation.
------------------------------
Richard Vincins RAC
Vice President Global Regulatory Affairs
Oriel STAT A MATRIX - ENTERPRISE
Original Message:
Sent: 31-May-2021 17:20
From: Kevin Randall
Subject: eIFU for Breast Implants in EU
- Regulation 207/2012 applies to all medical devices.
- Its provisions for providing eIFU instead of paper IFU only apply to certain devices, specifically those listed in Article 3 therein. No medical devices other than those encompassed by Article 3 are allowed to have eIFU instead of paper IFU.
- Whenever eIFU are provided in addition to paper IFU, whether that be for the Article 3 devices or for any other medical devices, then pursuant to Regulation 2017/745 (the "EU MDR") Annex 1 section 23.1, first paragraph, indent (f), then that must be done in accordance with the corresponding provisions of Regulation 207/2012. Yet indent (f) also blankets the provision pf eIFU instead of paper IFU where such provision is allowed by Regulation 207/2012.
- This means that for EU MDR Annex I section 23.1 first paragraph demanding that certain parts of the IFU (not the entire IFU) be placed on the website if the manufacturer has a website, then such eIFU must for any medical device be paired with paper IFU in accordance with the corresponding provisions of Regulation 207/2012 unless the device is an Article 3 device for which Regulation 207/2012's requirements have been met for providing eIFU instead of paper IFU.
- This interpretation has been verified with the European Commission during my related correspondence with them. Indeed, this interpretation seems to be the only logical interpretation allowed by Regulation 2017/745. And this interpretation is maintained in the aforementioned draft regulation (with one potential exception not relevant to the current discussion). I don't believe, and I don't think that the European Commission believes, that there is a conflict between Regulation 207/2012 and Regulation 2017/745, nor within Regulation 2017/745. Accordingly, it's better for us to do our best at understanding these requirements in their current legislative forms, as it doesn't appear that they will be changed.
------------------------------
Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
Principal Consultant
Ridgway, CO
United States
© Copyright 2021 by ComplianceAcuity, Inc. All rights reserved.
Original Message:
Sent: 31-May-2021 06:00
From: Richard Vincins
Subject: eIFU for Breast Implants in EU
Hi,
Just wanted to add a note, we live in the 21st century and dealing with 10+ languages for translations many opt for eIFU across the board. The regulation 207/2012 only applies for certain types of medical devices, implants being one of those eligible, so use caution when applying this to any medical device as your organisation can be challenged. The EU MDR regulation 2017/745 points back to regulation 207/2012 so plan to have "discussions" with your Notified Body if applying eIFUs for other type of products not on the so-called eligible list. The EU MDR itself is contradictory because if you read 23.1 it basically says if you have a website you must keep an electronic copy there, with no direct linkage to 207/2012 or section 23.1(f), and no apparent provisions for allowing eIFUs for any other devices as regulation 207/2012 is for specific devices. EU Commission first needs to step into the electronic age of the internet and second needs to update their regulation from 2012 (which in real time could have been written in 1880) to current industry practices. (And I still love the definition of a 'fixed installed medical device' chuckle) I just bring this up because we have many companies asking in they can do eIFU in Europe for their products since its common practice now in 2021 in many other regions especially with translating into 10+ languages.
------------------------------
Richard Vincins RAC
Vice President Global Regulatory Affairs
Oriel STAT A MATRIX - ENTERPRISE
Original Message:
Sent: 28-May-2021 03:52
From: Dirk Stynen
Subject: eIFU for Breast Implants in EU
Hi,
Kevin is right and gave references to the Regulation providing the basis for this.
The Regulation also defines all the requirements that apply to an eIFU solution. They are important as Notified Bodies will verify compliance with these requirements.
Best regards,
------------------------------
Dirk Stynen PhD
President
QARAD
Belgium
dirk.stynen@qarad.com
https://www.qarad.com/e-labeling-eifu
Original Message:
Sent: 27-May-2021 13:42
From: Kevin Randall
Subject: eIFU for Breast Implants in EU
Yes, for the EU market, breast implants are eligible for provision of eIFU instead of paper IFU. This is pursuant to the eIFU Regulation 207/2012 Article 3(1)(b).
And this remains the case in the new implementing regulation that has been drafted (i.e., not yet entered into force) by the Commission laying down rules regarding eIFU for the application of Regulation (EU) 2017/745.
------------------------------
Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
Principal Consultant
Ridgway, CO
United States
© Copyright 2021 by ComplianceAcuity, Inc. All rights reserved.
Original Message:
Sent: 27-May-2021 12:17
From: Carolina Oviedo
Subject: eIFU for Breast Implants in EU
Dear community
I would like to ask you to share your experiences related to provide breast implant devices into the EU market with eIFU instead of a paper IFU. Is this possible, according to regulations available and from the Notified Bodies perspective?
Thank you!
------------------------------
C.Oviedo
Sr. RA Specialist
------------------------------